Top Markets
Coin of the day
BioInvent International AB (publ) BioInvent International AB (publ)

BioInvent International AB (publ)

BINV
Rang in Aktien #19120
BioInvent International AB (publ) is a clinical-stage Swedish company dedicated... BioInvent International AB (publ) is a clinical-stage Swedish company dedicated to discovering, researching, and developing immunomodulatory antibodies for global cancer treatment, with reach across Sweden, Europe, the United States, and Japan. Its most advanced therapeutic candidate, BI-1206, targets non-Hodgkin lymphoma and various solid tumors. The company's diverse pipeline also features developments aimed at tumor-associated myeloid cells and cancer-associated regulatory T cells, which play a role in modulating the immune system, alongside BT-001 for solid tumors. Furthermore, BioInvent is progressing BI-1808 and BI-1910, a pair of anti-TNFR2 antibodies, designed to combat solid tumors and cutaneous T-cell lymphoma. Strategic collaborations are integral to its operations; these include a partnership with Pfizer Inc. for antibody development against tumor-associated myeloid cells, a co-development effort with Transgene involving multi-functional oncolytic viruses for solid tumors, and an agreement with Merck for the clinical advancement and supply of BI-1808. Established in 1996, BioInvent is based in Lund, Sweden.
Aktienkurs
$2.65
Marktkapitalisierung
$174.19M
Veränderung (1 Tag)
-2.47%
Veränderung (1 Jahr)
-23.88%
Land
SE
Handel BioInvent International AB (publ) (BINV)

Kategorie

Kursverlauf für BioInvent International AB (publ) (BINV)
Höchster Schlusskurs: $2.67 am 2026-08-01

Niedrigster Schlusskurs: $85.60 am 2001-06-01
Kursverlauf der Aktie von BioInvent International AB (publ) von 2001 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -5.41%
2025 -17.47%
2024 117.26%
2023 -47.80%
2022 -36.40%
2021 -5.87%
2020 76.83%
2019 -42.16%
2018 -14.67%
2017 -0.37%
2016 -38.44%
2015 41.60%
2014 -32.92%
2013 14.96%
2012 -78.97%
2011 -41.46%
2010 4.40%
2009 96.44%
2008 -30.58%
2007 116.26%
2006 -0.99%
2005 8.47%
2004 -15.33%
2003 0.92%
2002 -59.80%
2001 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$769.41 6.94%
CH